Since my last article, Gilead Sciences, Inc.'s stock price has continued ... of you to better understand how it works. As I said in “Amgen: Growth Is Still A Better Choice,” understanding ...

The company’s shares closed yesterday at $335.26. Yee covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Amgen, and Moderna. According to TipRanks, Yee has an average ...

High-rolling investors have positioned themselves bullish on Gilead Sciences GILD, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences rose 2% in early trading, after the biotech reported positive data for a long-acting HIV prevention drug that promises to be a big seller. The drug, called lenacapavir, was 96% ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Originally published by Gilead Sciences View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

About Gilead Sciences: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.

Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections Gilead Sciences' Phase 3 trial results show twice-yearly HIV-1 capsid inhibitor ...

By Rebecca Robbins and Sheryl Gay Stolberg A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V ...

Together, we drive innovation and further our mission to create a healthier world for all people. Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and ...

View Gilead Sciences, Inc. (GILD) current and estimated P/E ratio data provided by Seeking Alpha.